About
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient’s CIN status is prognostic for metastasis and ...
- Website
- Headquarters
- Industries
- Employees11-50
- Social
Photos
Add photos to showcase Volastra’s culture
Values
Add Volastra’s values
Insider experiences
Share your experience of working at Volastra
Org chart
View org chartTeams
View all (0)Add your teams to show how people work together at Volastra
Jobs
View all (0)Add jobs to your org chart to show candidates who they’ll work with
Wires
View all (0)Publish company announcements to get more exposure